Please login to the form below

Not currently logged in
Email:
Password:

Moderna Therapeutics appoints chief business officer

Saqib Islam brings experience from Alexion Pharmaceuticals

Moderna Therapeutics Saqib IslamCambridge, Massachusetts-based Moderna Therapeutics has appointed Saqib Islam as its new chief business officer from 9 May.

Islam will take on responsibility for Moderna's global strategic planning, corporate and business development functions as the biotech firm looks to advance its pipeline.

Stéphane Bancel, chief executive officer at Moderna, said: “We are thrilled to welcome Saqib to our team; his expertise, intellect and drive for excellence are a perfect fit for Moderna.”

Islam joins from Alexion Pharmaceuticals, where he served as executive vice president and chief strategy officer from 2013. In this role, he held primary responsibility for executing the firm's corporate growth strategies and oversaw the management of its global operations.

He brings over 20 years of international business management expertise to Moderna, having held increasingly senior roles at The Boston Consulting Group, Merrill Lynch, Morgan Stanley and Credit Suisse Securities.

Islam said: “Already a clinical stage company, Moderna has extraordinary opportunities ahead of it, with its breakthrough science, accelerated discovery engine and unique business model.

“I look forward to working closely with Stéphane and the leadership team as we evaluate these opportunities and evolve Morderna's internal development and external partnering strategies to support the creation and commercialisation of a new generation of transformative medicines for patients.”

12th April 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS Just::

HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value: Patient Involvement in Health Technology Assessment
Exploring the evolution of patient involvement in health technology assessment (HTA), and the role of the patient voice in market access....

Infographics